Counterfeiting of pharmaceuticals has become a big issue in recent years and the European Commission recently issued proposals to combat this. Amongst the proposed actions are increased auditing of the manufacturing and supply chain and unique identification of every pack.
Somerset House Consultants has been asked by a client to carry out a review of their manufacturing activities and implement improvements to combat the risk of counterfeiting of their products.
Somerset House Consultants helps pharmaceutical companies worldwide to select, audit and manage contractors for their outsourced development and manufacturing projects.
We provide quality assurance and Qualified Person release services for API, IMP and marketed products.
Our expert consultants ensure that work is carried out on-time, on-budget and in compliance with all current Good Manufacturing Practice requirements.